Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Growth Hormone-Secreting Pituitary Adenoma × Solutions × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pituitary Neoplasms 1 Insulinoma 1 Hyperinsulinism 1 Growth Hormone-Secreting Pituitary Adenoma 1 Congenital Hyperinsulinism 1 Acromegaly 1

Interventions

lanreotide 1 Temozolomide 1 Surveys and Questionnaires 1 Solutions 1 Radiosurgery 1 Observation 1 Microarray Analysis 1 Injections 1 Early Intervention, Educational 1 Diet, Mediterranean 1 Diet, Ketogenic 1 DNA Methylation 1 90Y-octreotide, DOTA-Tyr(3)- 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03439709 2018-03-01

MERGE

Samsung Medical Center

Phase 3 Unknown

Acromegaly, Pituitary Neoplasms, Growth Hormone-Secreting Pituitary Adenoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡